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Poor adherence to inhaled corticosteroids (ICSs) may contribute to the recent rise in
asthma morbidity. In general, appropriate adherence to ICSs is a complex process that is
influenced by various determinants. The purpose of this study was to identify factors that
were associated with adherence to ICSs in children with asthma and their parents in a
multi-ethnic population in Amsterdam, the Netherlands.
Two hundred and thirty-two children, aged 7–17 years, with paediatrician diagnosed
asthma and their parents completed questionnaires examining socio-demographics,
asthma control, knowledge of asthma and other determinants of adherence. Adherence
to ICSs was assessed by self-report and pharmacy record data. We used logistic regression
analyses to identify factors associated with adherence to ICSs in children and parents
separately.
We found no differences in adherence between the different ethnic groups. In the
multivariate analysis for children, well-controlled asthma (OR: 4.12; CI: 1.50–11.3) was
associated with poorer adherence, whereas positive subjective view of parents (OR: 0.45;
CI:0.25–0.81) and self-efficacy (OR:0.51; CI: 0.35–0.75) were inversely associated with
poorer adherence. A consistent result with the multivariate models for parents was theElsevier Ltd. All rights reserved.
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Q.M. van Dellen et al.756inversely significant association between poorer adherence and positive subjective view of
parents to use ICSs (OR: 0.39; CI:0.19–0.77).
Regardless of ethnic background, children positively stimulated by their parents to use ICSs
showed a better adherence than children who experienced less positive influences. These
results emphasise the importance of involving parents in the treatment of their child’s
asthma in order to enhance adherence to ICSs.
& 2008 Elsevier Ltd. All rights reserved.Introduction
Asthma is a major cause of chronic morbidity and mortality
throughout the world and there is evidence that its
prevalence has increased considerably over the past 20 years,
especially in children.1 However, there are some indications
that the increase in prevalence may have flattened or even
fallen in some countries in the last few years.2,3
Poor adherence to inhaled corticosteroids (ICSs) may
contribute to this asthma morbidity.1 In general, appro-
priate adherence to ICSs is a complex process that is
influenced by various determinants. Socio-economic and
demographic factors, such as education, income and ethnic
minority status,4 but also concerns about potential adverse
effects,5 misunderstanding of the ICSs controller therapy,
and poor patient–physician communication may all lead to
inappropriate adherence.6 In addition, patients’ attitudes
and beliefs about asthma and its treatment may be
important mediators of adherence.7,8
Analysis of determinants of adherence to ICSs should
preferably be based on a theoretic or socio-cognitive model.
Since there are no conceptual models for assessing ICSs
adherence, we used a simplified version of the integrated
change model,9 concentrated on our measurements (see Figure
1). In the context of adherence to ICSs, this model postulates
that using daily ICSs is a result of a person’s intention to use it.
Next, the intention to use ICSs is determined by three main
types of motivational factors: attitudes, social influences and
self-efficacy expectations. A person’s attitude towards a
specific behaviour (e.g. using daily ICSs) is a result of the
evaluation of expected positive and negative cognitive and
emotional consequences (e.g. ‘‘ICSs will make me obese’’).
Social influences can be described as the processes whereby
people directly or indirectly influence the thoughts, feelings or
behaviours of others. Self-efficacy expectations can be seen as
a person’s belief in his or her ability to perform the desired
behaviour. Improving adherence to ICSs is an important target
in asthma care, and hence the aim of this study is to investigate
which factors (see shaded parts in Figure 1) are associated with
adherence to ICSs in children with asthma. The study was
carried out among children of Moroccan, Turkish, Surinamese
and ethnic Dutch background, in order to gain insight into the
need to adapt self-management education programs in this
multi-ethnic population.Material and methods
Study participants
Children were recruited from a previously described
cohort.10 Among these 280 children, 232 (83%) agreed toparticipate in this study. Of the 48 non-respondents, almost
three quarters refused to participate, whereas one quarter
was untraceable. These non-respondents were equally
divided over the ethnic groups. Briefly, eligibility criteria
for the former study were: (1) paediatrician diagnosed
asthma, (2) attending a paediatric outpatient clinic, (3) age
between 7 and 17 years, and (4) of Moroccan, Turkish,
Surinamese or ethnic Dutch descent. Children were classi-
fied as belonging to an ethnic group other than Dutch if the
child itself or at least one of its parents was born outside the
Netherlands. Written informed consent was obtained from
all parents and from patients 12 years of age and older. The
study protocol was approved by the medical ethics
committee of all participating hospitals.Data collection and measurements
All children and parents were interviewed in a face-to-face
setting in their homes by trained interviewers. The ques-
tionnaire used during the interview was translated backward
and forward into Turkish and Arabic language. Dutch and
Surinamese parents were interviewed in Dutch, while
Turkish and Moroccan parents were interviewed in their
language of choice by a bilingual interviewer (Dutch and
Turkish, Dutch and Arabic or Dutch and Tamazight (Berber)).
To obtain information about the collected ICSs, we
examined the pharmacy records over a 12-month period
preceding the home visit.Outcome: adherence to ICSs
In this study we focused on the adherence to ICSs as a
significant part of self-management behaviour. As current
use of ICSs was not an inclusion criterion for the previously
described cohort,10 children not using their ICSs on a daily
basis in accordance with their doctor’s advice were excluded
from the analyses in this study. We assessed adherence to
ICSs by 3 different components (1, 2a and 2b) obtained by
self-report and electronic pharmacy records. We differen-
tiated adherence in good and poor adherence.Self-report on ICSs usage
All children were asked about their usage of ICSs: ‘‘With
respect to the last year, how often do you use your ICSs?’’ If
the child was less than 12 years old, information about the
use of ICSs was obtained from the parents. ‘‘How often does
your child use his/her ICSs?’’
We dichotomized the answer in ‘‘daily users’’ (good
adherence) and ‘‘non-daily users’’ (poor adherence).
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Figure 1 Simplified version of I-change model.9
Medication adherence in children with asthma 757Pharmacy records on ICSs collections
Firstly, with the use of pharmacy records, we counted the
total number of ICS collections per patient over a period of
12 months. Metered dose inhalers, dry powder inhalers and
nebuliser ampoules were all included. The pharmacy
database contained the dispensing date, product name,
strength and dosage form. Secondly, we calculated the
mean number of puffs per day per child by counting the total
number of ICS collections in the 12-month period, and
multiplying this by the total puffs per unit (which could
be different for each other unit). Thereafter we divided the
sum by 365 days. We differentiated in two components (a+b)
and dichotomized the answers:(a) ‘‘Collecting’’ (good adherence) and ‘‘non-collecting’’
(poor adherence) at least 1 prescription of ICSs during a
12-month period.(b) ‘‘41 mean puff ICS per day’’ (good adherence) and ‘‘o1
mean puff ICS per day’’ (poor adherence).Predisposing factors
Socioeconomic and (socio-)demographic information
The parental level of socioeconomic status (SES) was
assessed using valid indicators, such as highest level of
education, occupation and net household income per
month.11 We constructed a questionnaire on socio-demo-
graphic factors. Moreover, Turkish and Moroccan parents
were classified into ‘‘sufficient’’ or ‘‘insufficient’’ compre-
hension of the Dutch language according to their compre-
hension of this country’s primary language, as indicated by
the need for a bilingual interviewer.
Asthma control
Asthma control was assessed using the original Dutch version
of the Asthma Control Questionnaire (ACQ), developed by
Juniper and colleagues. Patients recall their asthma-related
experiences during the previous week and respond to each
of the six questions using a 7-point scale that ranges from 0
(well controlled) to 6 (extremely poor controlled). The ACQ
was dichotomized to identify patients whose asthma was
well or not well controlled. To be confident that patientshave well controlled asthma, the optimal cut-off point is
0.75 (mean score of six items).12
Awareness factor
Asthma knowledge
Parental knowledge of asthma was measured using the
Asthma Knowledge Questionnaire developed by Ho and
colleagues.13 This is a 25-item instrument formulated to
measure components of parental asthma knowledge, and
relevant for paediatric asthma management. A cut-off point
of 13 correct answers was used to differentiate between
sufficient and insufficient knowledge. This cut-off point was
based on the participant’s mean score of correct answers.
Motivational factors
In order to assess motivational factors, we constructed a
questionnaire based on the results of focus group sessions.
An additional criterion for the focus group interviews was
that the children were prescribed an ICS in the year prior to
the focus group sessions. Initially we developed the self-
management questionnaire for assessing a variability of
motivational factors on different aspects of self-manage-
ment behaviour. However, this study will only show the ICSs
adherence-related questions, since we only measured the
use of ICSs as dependent outcome of self-management
behaviour.
Self-management questionnaire
The same questionnaires were constructed for children and
parents. The examples described here are related to the
child questionnaire.
Intention state was assessed by the question: ‘‘Do you
have the intention to use your ICSs daily in the near future?’’
Attitude towards daily use of ICSs was measured by five
beliefs about the perceived consequences of daily using ICSs
(e.g. ‘‘If I use my ICSs daily, I have a smaller risk of having an
asthma attack’’). Two sub-scales were constructed: advan-
tages (positive attitude) of daily using ICSs (two items) and
disadvantages (negative attitude) of daily using ICSs (three
items). We constructed the same subscales for parents:
advantages (two items) and disadvantages (three items).
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Table 1 Characteristics of the participating children
and their parents (n ¼ 232).
No. of participants
n (%)
Total no. of participants 232 (100)
Dutch 77 (33)
Moroccan 67 (29)
Turkish 45 (20)
Surinamese 43 (18)
Children characteristics
Gender
Boys 142 (61)
Girls 90 (39)
Age
7–12 years 147 (63)
13–17 years 85 (37)
Asthma control
Well-controlled 142 (61)
Not well-controlled 88 (38)
Missing 2 (1)
Parent characteristics
Single-parent family
Yes 42 (18)
No 190 (82)
Education
Yes 157 (68)
None or primary education
only
75 (32)
Occupation
Skilled labourer 124 (53)
Manual labourer 64 (28)
Homemaker 44 (19)
Household income (net per month)
o1600 euro 119 (51)
41600 euro 71 (31)
Missing 42 (18)
Level of asthma knowledge
Sufficient 100 (43)
Insufficient 130 (56)
Missing 2 (1)
Comprehension of Dutch
(Moroccan and Turkish parents n ¼ 112)
Sufficient 44 (39)
Insufficient 68 (61)
1.0 Euro 1.3 US dollars.
Q.M. van Dellen et al.758Social influences were measured by two individual items:
(1) subjective view of parents regarding daily use of ICSs.
This item assessed the perceived beliefs about using ICSs of
the parents (‘‘My mother/father thinks that daily use of ICSs
is an important part of the treatment of asthma) and (2)
social support for using ICSs daily (‘‘My mother/father
reminds me daily to take my ICSs’’). Both components were
assessed by one question.
Self-efficacy was assessed by one item (‘‘How difficult will
it be for you to take your ICSs on a daily basis in the near
future?’’).
Statistical analysis
Statistical analysis was performed using SPSS (version
12.0.1, Chicago, USA). Descriptive statistics were used to
describe baseline characteristics. Means and standard
deviations of the continuous variables were calculated and
proportions were computed for all categorical variables.
The outcome variable, adherence to ICSs, was converted to
a binary variable, good and poor adherence. We used three
different models: (1) daily users vs. non-daily users of ICSs,
(2a) collecting vs. non-collecting of ICSs and (2b) X1 mean
puff ICS per day vs.o1 mean puff ICS per day. For univariate
analyses comparing individual determinants to adherence,
Pearson’s w2 tests were used for categorical variables,
Student’s t-tests for continuous variables and Mann–Whitney
tests for not normally distributed continuous variables.
Outcomes showing a significant relationship to adherence
(pp0.10) in the univariate analyses were entered into a
multivariate logistic regression model. Poor adherence was
coded as 1 in the model and therefore odds ratios (ORs) can
be interpreted as the odds of having poor adherence. In the
final model, a p-value o0.05 was considered statistically
significant.14
The self-management questionnaire developed for this
study was tested for reliability of internal consistency using
Cronbach’s alpha coefficient. Reliability is considered
acceptable for group comparison if aX0.70. For those
variables with relatively low consistency measures (Cron-
bach’s alpha) the individual items were tested for associa-
tion with adherence.
Results
Patient characteristics
Demographics of the participants are shown in Table 1. Of
the 232 (61% male) participants, 77 (33%) were Dutch, 67
(29%) were Moroccan, 45 (20%) were Turkish and 43 (18%)
were Surinamese. Almost 61% of all children had well-
controlled asthma as indicated by the ACQ. More than half of
the parents (53%) were skilled labourers, while 32% had none
or primary education only. Only 39% of Moroccan and Turkish
parents had a good comprehension of the Dutch language.
Intention state
Of all children not using their ICSs on a daily basis, 34% had
the intention to possibly use them daily, while also 34% hadthe intention to definitely use them daily in the near future.
Twenty-one percent of the parents of children not using ICSs
daily, had the intention to possibly let their children use ICSs
daily, while 42% had the intention to definitely let their
children use their ICSs daily in the near future (data not
shown in table).
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In Table 2 an overview of adherence is shown. Of all 232
children, 63 children (27%) reported not using their ICSs on a
daily basis, in accordance with their doctor’s advice. These
63 children were excluded for further analyses. Of the
remaining 169 children, 75% reported they used their ICSs on
a daily basis and 88% collected at least one prescription of
ICSs during a 12-month period. Only 46% of all children used
more than one puff ICS per day. Overall there were no
statistically significant differences in adherence between
the four ethnic groups. Of all 232 parents, 75 parents (32%)
were excluded for further analyses since these parents
reported that their children did not use their ICSs on a daily
basis, in accordance with their doctor’s advice. The relative
internal consistency of responses provided by both groups
was calculated by using a reliability analysis (expressed in
Cronbach’s alpha coefficient). Reliability is considered
acceptable for group comparison if aX0.70. It turned out
that there was a poor relative internal consistency between
the answers provided by children and parents, since all
alpha’s were smaller than 0.70 (0.21Xap0.55).
Possible significant differences in the absolute values of
responses provided by children and parents were calculated
by using Paired-Samples T Test. Except for the disadvantages
‘‘ICSs makes me fat’’ and ‘‘ICSs makes me small for my age’’
and the social influences ‘‘Subjective view of parents’’ all
answers provided by children vs. parents differed signifi-
cantly (o0.05).Adherence models
Tables 3a and b presents the univariate relationship in
children and parents, respectively, between potential
determinants and adherence to daily usage of ICSs (model
1). The univariate relationship between predictors and
adherence to collecting ICSs (model 2a) and X1 puff ICS
per day (model 2b) are not shown because these had similarTable 2 Measurements of adherence (n ¼ 169) in percentages
Total n (%) Dutch n (%)
Number of participants 169 (100%) 57 (34%)
Self-report
1. Daily use of ICSs
Yes 126 (75%) 37 (65%)
No 43 (25%) 20 (35%)
Pharmacy record data over 1 year
2a. Collecting ICSs at pharmacy
Yes 148 (88%) 49 (86%)
No 21 (12%) 8 (14%)
2b. Mean puffs ICS per day
X1 puff per day 77 (46%) 26 (46%)
o1 puff per day 92 (54%) 31 (54%)
Mean puffs ICS per day (7SD) 1.13 (70.86) 1.12 (70.8
ICSs, inhaled corticosteroids.results. Cronbach’s alpha for the child version for positive
attitude was 0.60, and for negative attitude 0.33; for
parents: positive attitude 0.67 and negative attitude
0.16. Because of the relatively low consistency measures
(Cronbach’s alpha) we only focused on the individual items
and not on the mean scores. In addition, non-parametric
tests in small and not normally distributed groups yielded
similar statistically significant results.
Table 3a illustrates that children with well-controlled
asthma show significantly poorer adherence than children
with not well-controlled asthma (po0.001). Furthermore,
children who experienced more positive stimulation of their
parents to use ICSs showed significantly better adherence
than the children who experienced less positive stimulation
(po0.001 for both items) and children with a high self-
efficacy showed statistically significant better adherence
than children with a low self-efficacy (po0.001). With
regard to this model 1, presenting adherence to daily use of
ICSs, when all significant variables (pp0.10) were entered
into the multivariate logistic regression analysis, well-
controlled asthma (OR: 4.12; CI: 1.50–11.3) was indepen-
dently associated with poorer adherence, whereas positive
subjective view of parents (OR: 0.45; CI:0.25–0.81) and self-
efficacy (OR:0.51; CI: 0.35–0.75) were inversely associated
with poorer adherence. Regarding model 2a, presenting
adherence to collecting of ICSs, positive subjective view of
parents (OR: 0.54; CI: 0.31–0.94) and well-controlled
asthma (OR: 3.6; CI: 1.00–13.1) were the only two
independently associated factors for poorer adherence. In
model 2b, presenting adherence to 41 puff ICS per day,
none of the variables showed any statistically significant
association.
Table 3b illustrates the univariate relationship for parents
between the predictor variables and adherence to daily usage
of ICSs (model 1). All parent multivariate models showed
an inversely statistically significant association between the
positive subjective view to ICSs of the parents and poor
adherence (model 1: OR: 0.39; CI:0.19–0.77, model 2a:
OR:0.45; CI:0.25–0.82, model 2b: OR: 0.50; CI:0.28–0.89).per ethnic group, unless stated otherwise.
Moroccan n (%) Turkish n (%) Surinamese n (%) p
44 (26%) 33 (19%) 35 (21%)
0.1
38 (86%) 24 (73%) 27 (77%)
6 (14%) 9 (27%) 8 (23%)
0.17
42 (96%) 26 (79%) 31 (89%)
2 (4%) 7 (21%) 4 (11%)
0.71
23 (52%) 14 (42%) 14 (40%)
21 (48%) 19 (58%) 21 (60%)
7) 1.33 (70.94) 0.97 (70.76) 1.02 (70.82) 0.24
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Table 3 (a) Univariate analysis: factors associated with adherence to daily usage and non-daily usage of inhaled
corticosteroids (ICSs) assessed by children (n ¼ 169); (b) (n ¼ 157).
Adherence
Variable Daily usersy Non-daily
usersy
p
(a)
Children
Predisposing factors 126 43
Ethnicity 0.1
No. of Dutch children 37 20
No. of Moroccan children 38 6
No. of Turkish children 24 9
No. of Surinamese children 27 8
Girls/boys 53/73 13/30 0.17
Age child in years 11.672.50 12.072.22 0.29
Well-controlled/not well-controlled asthma 61/65 34/9 o0.001
Education parent yes/no 89/37 32/11 0.64
Occupation parent 0.25
No. of skilled labour 67 28
No. of manual labour 40 8
No. of homemaker 19 7
No of households with o1600 Euro/X1600 Euro (n ¼ 136) 67/36 20/13 0.64
Single-parent family yes/no 23 103 8/35 0.96
Comprehension of Dutch language sufficient/insufficient 85/41 36/7 0.04
Awareness factor (n ¼ 167)
Level of asthma knowledge sufficient/insufficient 54/70 18/25 0.85
Motivational factors
Attitude towards daily use of ICSs
Advantagesz,y 3.2770.54 3.0470.74 0.13
It keeps my asthma under controlz 3.2870.60 3.1470.74 0.35
It reduces the risk of having an asthma attackz 3.2570.74 2.9870.87 0.07
Disadvantagesz,y 0.7270.70 0.5070.39 0.11
It is annoyingz 1.5271.21 1.2371.13 0.19
It makes me fatz 0.2870.85 0.1170.54 0.26
It makes me short for my agez 0.3770.97 0.1470.68 0.12
Social influences
Subjective view of parentsJ 1.7770.48 0.7771.38 o0.001
My mother/father thinks that daily use of ICSs is an important part of
asthma treatment
Social support 2.8771.26 1.8171.53 o0.001
My mother/father reminds me daily to take my ICSs
Self-efficacyyy 1.4070.92 0.2371.49 o0.001
It will not be difficult for me to take my ICSs daily in the near future
(b)
Parents
Predisposing factors 124 33
Ethnicity 0.14
No. of Dutch children 39 14
No. of Moroccan children 40 4
No. of Turkish children 21 6
No. of Surinamese children 24 9
Girls/boys 52/72 11/22 0.37
Age child in years 11.472.41 12.272.67 0.07
Well-controlled/not well-controlled asthma 62/62 24/9 0.02
Education parent yes/no 89/35 27/6 0.24
Occupation parent 0.22
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Table 3 (continued )
Adherence
Variable Daily usersy Non-daily
usersy
p
No. of skilled labourer 68 21
No. of manual labourer 37 5
No. of homemaker 19 7
No of. households with o1600 Euro/X1600 Euro (n ¼ 127) 63/36 17/11 0.78
Single-parent family yes/no 19/105 6/27 0.69
Comprehension of Dutch language sufficient/insufficient 83/41 29/4 0.02
Awareness factor
Level of asthma knowledge sufficient/insufficient 57/67 17/16 0.57
Motivational factors
Attitude towards daily use of ICSs
Advantagesz,y 3.5470.52 3.1570.67 0.002
It keeps the asthma of my child under controlz 3.5570.60 3.0970.84 0.001
It reduces the risk of having an asthma attackz 3.5370.60 3.2170.70 0.01
Disadvantagesz,y 0.9370.66 0.7070.51 0.08
It is annoyingz 1.9471.15 1.8171.10 0.62
It makes my child fatz 0.3570.96 0.2170.86 0.3
It makes my child short for his/her agez 0.5071.14 0.0970.52 0.04
Social influences
Subjective view of parentsJ 1.8170.50 1.0971.13 o0.001
My child knows that I think daily use of ICSs is an important part of
asthma treatment
Social support 3.1371.17 2.8171.16 0.07
I remind my child daily to take his/her ICSs
Self-efficacyyy 1.5870.77 0.9771.36 0.01
It is not difficult for me to let my child take his/her ICSs daily in the
nearby future
Mean7SD unless otherwise specified; t-test or non-parametric equivalent.
yNo. of children differed for income.
z4 ¼ many advantages; 0 ¼ no advantages.
yMean positive and negative attitude.
z4 ¼ many disadvantages; 0 ¼ no disadvantages.
J2 ¼ negative view; 2 ¼ positive view.
4 ¼ much support; 0 ¼ no support.
yy2 ¼ low self-efficacy; 2 ¼ high self-efficacy.
Medication adherence in children with asthma 761Discussion
We conducted a cross-sectional study of 232 children with
paediatrician diagnosed asthma to examine potential
determinants of adherence to ICSs in a multi-ethnic
population. This study gives a unique overview of the
combined determinants of adherence amongst these chil-
dren and their parents. We found no differences in
adherence between the different ethnic groups. The main
result of this study is that a positive subjective view
of parents towards ICSs was associated with good adher-
ence. Therefore, regardless of ethnic background, children
positively stimulated by their parents to use ICSs showed
a better adherence. Although ICSs are the cornerstone
of asthma therapy, patients tend to under-use these
medications.1 These medications are time-consuming and
inconvenient to use and offer no immediate perceivablebenefit. Adherence to ICSs is poor in all patient groups.4
Apter et al. examined 50 adults from different ethnic
origins living in Connecticut, US, with moderate to severe
asthma, who had been regularly prescribed ICSs. Adherence
was measured by counting actuations of prescribed ICSs
as recorded by the electronic device. They found that
lower SES and poor patient–clinician communication were
independently associated with poor adherence to ICSs.4
Another study by Apter et al., similar in design, also
described an association between a low SES and poor
adherence.15 We could not confirm the association between
low SES and adherence. A possible explanation could
lie in the homogenous composition, with respect to SES
of our sample size. The level of income plays no role
in medication adherence as all medication costs are
completely covered by the health insurance system in the
Netherlands.
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mentioned study of Apter et al. a negative association
between minority status and adherence was found, although
this was no longer significant in the multiple logistic
regression analysis.4 This poor adherence to ICSs in ethnic
minority children has been described in other US stu-
dies.16–18 In the Netherlands these kind of studies are scarce
and there is not much evidence for ethnic differences in
patterns of adherence. However, we found one study of
Uiters et al. in which they examined the concordance
between self-reports and medical records concerning
utilisation of prescription medication among different
ethnic groups living in the Netherlands. The results of this
study show that the level of agreement did not differ
systematically between the ethnic groups, implying that the
validity of self-reported data concerning use and receipt of
prescription did not differ among the ethnic groups. This
suggests that the discordance between self-reports and
medical records data might not be fully perceived as a cross-
cultural validity issue. Especially among the Moroccans and
Turks, compliance with prescribed medication by the
general practitioner is suggested not to be optimal.19 We
did not find any significant differences in the three models
among the different ethnic groups.
In accordance with our results, Apter et al. also found
that a positive attitude towards ICSs is an important
determinant for a better adherence. However, this was only
a significant association in our univariate analyses of the
parent models.
Consistent with the information from our focus group
study is that children who experienced more positive
influences of their parents to use ICSs tend to be more
adherent. The majority of the children in our focus groups
were not adverse towards their ICSs. However, most children
expressed that they take their ICSs because their parents
told them to, and not because they were aware of the
positive effects of ICSs. In other diseases, such as ADHD and
HIV, poor adherence to daily medication was also associated
with poor family support and decreased interaction with
parents.20,21 Haynes et al. proposed that effective ways to
help people adhere to medical treatment would have far
greater effects on health than any treatment itself.22
There is a wide-ranging disparity in adherence, which
emphasises the need to use reliable measures to distinguish
between patients who adhere to the therapeutic regimen
and those who do not, both in clinical practice and research.
For example, most studies used self-report to measure
adherence, largely ignoring sizable literature establishing
that patients greatly over report adherence.23 For children
with asthma, the average medication adherence rate of 48%
was determined by a meta-analysis of 10 studies.24 Similar
findings have been reported for adult patients.25 There was
a wide-ranging disparity in adherence in our study, ranging
from 88% (collecting ICSs at pharmacy) to 46% (41 puff ICS
per day). This 88% is most probably a result of over-report.
The 88% only indicates the collection of at least one
prescription of ICSs during a 12-month period regardless of
the prescriptions of their physician. This percentage does
not reflect the actual use and the 75% adherence measured
by self-report is probably also an overestimation. When we
used international guidelines as guidance of adherence
(puffs per day),26 our adherence rate dropped to 46%. This isprobably a better reflection of reality. In our opinion it
would have been the same if we presented in Tables 3a and b
factors associated with adherence to daily and non-daily use
of ICSs based on pharmacy records instead of self-report,
since all uni- and multivariate models showed similar results
(statistically significant association).
A remarkable finding was that good asthma control was
inversely associated with non-adherence. Most likely, good
asthma control coincides with mild asthma, and this inverse
association is due to selection bias. Children with good
asthma control are most likely to stop the use of their ICS
because of the absence of symptoms. A recent study in
which this same inverse relation was observed is a study by
van Gent et al. in which the authors describe the same
association between medication refusal and mild asthma.27
The explanation is simple: the lesser the symptoms of a
child, the less likely he/she is to use medication on a daily
basis.
Critical remarks about the present study must be made.
Firstly, the cross-sectional design of the study makes it
impossible to draw conclusions about causality in the relations
found in this study. Stronger support for these relations should
be obtained in the future on the basis of prospective studies
with a longitudinal design. Secondly, the internal consistency
of the attitude questionnaire was low, suggesting that perhaps
more than one theme is depicted in the question set.
Therefore we analysed each item individually.
A strength of this study is that we used the data of parents
in addition to that of children. Since asthma management in
(young) children is highly dependent on parents, parental
motivational factors and intention state can also be
significantly related to adherence to ICSs of the child and,
therefore, we developed the same questionnaire for the
parents.
Improvement of adherence by patients and the use of
best available evidence by physicians are needed to diminish
the intolerably high morbidity associated with asthma.
There is no single solution that will improve adherence in
all patients. The best treatment strategies include those
that are brief, easily implemented and can be tailored to
individual patients and diverse clinical settings. More
comprehensive interventions targeting both patients and
health caregivers may be promising but require further
objective evaluation. In accordance with the results of our
study, the patient/family–physician relationship is central to
the improvement of patient adherence.28 Consults that
ended without mutual agreement more often resulted in
poor adherence with prescribed therapy, especially among
patients with an ethnic-minority background.29
In conclusion, regardless of ethnic background, children
who experienced more positive influences of their parents to
use ICSs showed a better adherence than children who
experienced less positive influences. These results empha-
sise the importance of involving parents more actively in the
treatment of the asthma of their children, in order to
enhance adherence to ICSs.Conflict of interest statement
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